Mission Bay is the Bay Area's growing hub for biotechnology and has enjoyed great success in attracting entrepreneurs and innovators of all sizes. Terry Hermiston, Vice President of Biologics Research and head of the US Innovation Center for Bayer Healthcare; Regis Kelly, Director of the California Institute for Quantitative Biosciences (QB3) and former vice chancellor of UCSF; Gail Maderis, BayBio President and CEO; and Todd Rufo, Director of Business Development from the Office of Economic and Workforce Development for the City and County of San Francisco discuss the status of the biotech boom in Mission Bay and what comes next.